The reciprocal regulation between mitochondrial-associated membranes and Notch signaling in skeletal muscle atrophy

  1. Faculty of Medical Sciences, Fujita Health University, Toyoake, Japan
  2. Department of Biomedical Engineering, Faculty of Life and Medical Sciences, Doshisha University, Kyotanabe, Japan
  3. Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan
  4. Organization for Marine Science and Technology, Nagasaki University Graduate School, Nagasaki, Japan
  5. Department of Nutritional Physiology, Institute of Medical Nutrition, Tokushima University Graduate School, 3-18-15 Kuramoto-cho, Tokushima, Japan
  6. Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan
  7. Department of Anatomy, Faculty of Medicine, Fujita Health University, Toyoake, Japan
  8. International Center for Cell and Gene Therapy, Fujita Health University, Toyoake, Japan

Peer review process

Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, and public reviews.

Read more about eLife’s peer review process.

Editors

  • Reviewing Editor
    Graziana Colaianni
    University of Bari, Bari, Italy
  • Senior Editor
    Carlos Isales
    Augusta University, Augusta, United States of America

Reviewer #1 (Public Review):

In this study, the authors investigated the role of MAM and the Notch signaling pathway in the onset of the atrophic phenotype in both in vivo and in vitro models. The rationale used to obtain the data is one of the main strengths of the study. Already from the reading, the reasoning scheme used by the authors in setting up the study and evaluating the data obtained is clear. Using both cellular and mouse models in vivo consolidates the data obtained. The authors also methodologically described all the choices made in the supplementary section. A weakness, on the other hand, is the failure to include averages and statistical data in the results that would give a quantifiable idea of the data obtained. To complete the picture, the authors could also investigate the possible involvement of the intrinsic apoptosis pathway as well as describe probable metabolic shifts to muscle cells in atrophic conditions. The rationale used by the authors to obtain the result is linear. The data obtained are useful for understanding the onset and characterization of the atrophic phenotype under disuse and microgravity conditions. The methods used are in line with those used in the field and can be a starting point for other studies. The cellular models are well described in the materials and methods section. The selected mouse models followed a logical rationale and were in line with the intended aim.

Reviewer #2 (Public Review):

In this study, the authors examined how the maintenance of mitochondrial-associated endoplasmic reticulum membranes (MAM) is critical for the prevention of muscle atrophy under microgravity conditions. They observed, a reduction in MAM in myotubes placed in a microgravity condition; in addition, MFN2-deficient human iPS cells showed a decrease in the number of MAM, similar to in myotubes differentiated under microgravity conditions, in addition to the activation of the Notch signaling pathway. The authors, moreover, observed that treatment with the gamma-secretase inhibitor with DAPT preserved the atrophic phenotype of differentiated myotubes in microgravity and improve the regenerative capacity of Mfn2-deficient muscle stem cells in dystrophic mice.

The entire study was well conducted, bringing an interesting analysis in vitro and in vivo of aging conditions. In my opinion, it is necessary to improve the analysis of both genes and proteins to better support the conclusions

The study can contribute to a better understanding of one of the major problems of aging, such as muscle atrophy and inhibition of muscle regeneration, emphasizing the importance of the NOTCH pathway in these pathological situations. The work will be of interest to all scientists working on aging.

  1. Howard Hughes Medical Institute
  2. Wellcome Trust
  3. Max-Planck-Gesellschaft
  4. Knut and Alice Wallenberg Foundation